Caspofungin as Prophylaxis in High Risk Liver Transplantation Recipients

• Status: Unknown status
• Trial end date: 2012-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to determine viable use of caspofungin in post-OLTx patients, and to demonstrate in particular the effectiveness, understood as the ability to reduce the incidence of invasive fungal infections, and to assess the ability to reduce the risk and incidence of side effects (toxicity) which may arise in transplant patients treated with other drugs, especially in individuals recognized as high risk (e.g. renal failure).

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Azienda Ospedaliera di Padova
• Collaborator: Merck Sharp & Dohme Corp.
• Treatments: Caspofungin; Echinocandins

Criteria

Inclusion Criteria:

• patients shortlisted for liver transplantation

• negative pregnancy test for fertile female patients 7 days prior enrollment

• patients who can adequately communicate with study responsibles, who can understand and answer to protocol requirements

At least one of the following criteria:

• MELD score ≥25

• liver transplantation for acute liver failure

• liver re-transplantation

• fever without bacterial or viral infection

• biliodigestive

• re-laparatomy after LTx

• post LTx pancreatitis

• post LTx dialysis or renal insufficiency

Exclusion Criteria:

• Patients enrolled in other clinical trial or those having received other experimental drugs 4 weeks prior to enrollment

• Patients with a known fungal infection (based on the EORTC/MSG criteria)

• Patients with history of hypersensitivity to the drug, or other counterindications

• Patients with a diagnosed Severe Hepatic insufficiency (CTP >9)

• Physical or hematochemical alterations

• Clinically relevant psychological alterations in the 2 weeks preceding enrollment such as to interfere, in the researchers opinion, with the goal of the study

• Patients being treated with Ciclosporin A

Subjects being removed from the trial shall be replaced.